1 / 18

John Mulligan, October 16, 2006 Invention to Startup Seminar

John Mulligan, October 16, 2006 Invention to Startup Seminar . My Background. Trained as a geneticist BS in biology from MIT Ph.D. with Sharon Long at Stanford Biology Department Post-Doc with Ron Davis in Stanford Biochemistry Dept. Helped set up Human Genome Center at Stanford

Pat_Xavi
Download Presentation

John Mulligan, October 16, 2006 Invention to Startup Seminar

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. John Mulligan, October 16, 2006 Invention to Startup Seminar

  2. My Background • Trained as a geneticist • BS in biology from MIT • Ph.D. with Sharon Long at Stanford Biology Department • Post-Doc with Ron Davis in Stanford Biochemistry Dept. • Helped set up Human Genome Center at Stanford • Director of Genomics at Darwin Molecular • Applying genomics / genetics to drug discovery (1993-1999) • Founded Blue Heron • Scientific strength of Darwin Molecular • Clear business goals • Strong links between business and scientific planning

  3. GeneMaker® Gene Synthesis: Get the Gene You Want • Customer orders via secure website • Blue Heron manufactures and ships DNA molecule(s) • About 2 to 4 weeks later, customer receives exactly the DNA they wanted • No QC necessary: can download sequence trace data from their secure website • Start experiment right away

  4. Blue Heron Biotechnology, Inc. • Custom gene synthesis • Fee-for-service • No downstream ties • Service business based on an assembly-line production process • Unique products for every customer • Uniform assembly process • Automated, scalable, database controlled • Large potential market • $300-$400 million spent on reagents for cloning • Fully-loaded costs 3- to 5-fold larger ($1 to $2 B) • Current gene synthesis market ~$25 million (~2% of potential)

  5. Blue Heron Biotechnology, Inc. • Established in 1999 • Started with a product idea and developed the technology for this product • Venture funding in 2000 • Commercial launch in 2001 • SBIR funding • Phase I and II SBIRs, tightly focused on business needs • Now use robots developed with first Phase II SBIR • Projecting sustained profitability by mid-2007 • Plan to exit through acquisition

  6. Starting a Technology-Based Company • Business Model • Integration of scientific and business planning • The role of professional managers (MBAs) in a technical organization • Financing strategies • Rewards and costs

  7. Business Model • How will the company make money? • Who is the customer? • How will they buy your product? • What will it cost to make? • How will you get the information to customers? • How is this different from what is currently available? • Realistic knowledge of the market helps • A founder or advisor with direct experience (business development, sales, marketing, etc.) • Try to sell something as early as possible • Reality check, experience, new ideas, MONEY

  8. Scientific and Business Planning • Many companies, big and small, fail to integrate business and scientific planning • Science should address business needs • Business goals and plans should correspond to scientific realities • Science is unpredictable, business planning is all about predictions… • Both need to be adjusted regularly to continue to match

  9. Professional Managers • Many reasons to choose professional managers (~MBAs) • May be needed to raise capital • Tackle the vast number of details in starting an organization • As a scientist starting a business you have two choices • Do a job you are untrained for and may not like • Give the job to someone who may not understand the most important issues the business will face • Hiring a CEO who is not steeped in the technology can be very risky while technology is the main issue

  10. Poor Management is at the Root of Many Failures • Scientists may fail to understand how to • Focus on the critical issues for the business • Manage a large, disparate group of people • Do business development successfully • Make money • Managers may fail by • Not understanding science and scientists • Managing too much • Focusing on GANT charts • “Micro-managing” • Hiring other professional managers • “Death by vice presidents” • Making decisions that are based on business needs rather than technical reality

  11. Managing Your New Company • Find a scientist to run the company when science is the main issue • Confident but not an egomaniac • Understands science but willing to be wrong • Industry experience a big plus • Support with business skills early • Controller very early, CFO as soon as you can afford one • MBA business development, product development or sales • But not so soon that they have nothing to do- they will start managing whether or not it is needed… • Replace CEO with professional manager when appropriate

  12. Investment Financing • Venture financing vs. “friends and family” • Venture financing • Required for many biotech businesses • Best chance of getting the technology in use • 50% - 80% of your effort while pursuing financing • Will consume 20% to 30% of your effort on an ongoing basis • Don’t believe the “added value” stuff- it’s the money • Money may get more “expensive” as the company matures • Fantasy, reality, (partial) success, SUCCESS

  13. Bootstrap Financing • Many companies start this way • Sustaining this model depends on getting revenue quickly • Not feasible for some types of companies • Blue Heron is based on a capital-intensive manufacturing process • Government grants and partnerships may expand the range of companies that grow this way • R&D funding • Clinical trial support • Contracts • Many of the biggest returns to the founders have been from bootstrapped companies

  14. Rewards and Costs • Professional • Financial • Personal

  15. Professional Rewards and Costs • Expanded scope for projects • SIZE: Larger teams allow you to tackle problems of larger size and complexity • COMPLEXITY: Easier to form and manage multidisciplinary teams • Concrete impact of your ideas • Often the value of basic research, while clear, is abstract • Putting an effective new therapeutic or a new tool software engineering on the market impacts peoples lives • Learning experience • Focus on completion • Excel skills…

  16. Financial Rewards and Costs • Potential for return implicit in any business • Starting a company not the surest route to $$ • Many small bets may be better if financial returns are your goal (e.g., consult for several companies) • Conflict between maximizing financial return and professional or personal goals • Requires an investment, even if you are using “other people’s money” • Time • Salary • Attention • Go in with clear (written?) limits on total investment

  17. Personal Rewards and Costs • Satisfaction in building a company where people want to work • Stress • There is always more to do than you can finish • If you fail the happy people mentioned above lose their jobs • Payroll comes every 2 weeks • Conflict with the home front • Time: committed to a 45-50 hour week, still hard on family • Emotional: worries and stress can spill over • Statistical: up there with remodeling your house

  18. Summary • Have a good business model before you start • Test the model with experienced advisors • Try to sell something- products, deals, pet care • Find a scientist to run the company while science is the main issue • Provide strong business advisors and support early • Be ready to switch when business issues are most important • Choose the timing for venture financing carefully • Best returns from boot-strapped companies • Better chance of getting the technology out and getting some return with venture capital • Consider the rewards and costs

More Related